Capstone Wealth Management (Alabama)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.31M Buy
1,096
+593
+118% +$606K 0.61% 23
2026
Q1
$463K Hold
503
0.32% 33
2025
Q4
$541K Buy
503
+4
+0.8% +$3.83K 0.39% 30
2025
Q3
$381K Buy
499
+8
+2% +$5.95K 0.29% 38
2025
Q2
$383K Buy
491
+170
+53% +$132K 0.34% 33
2025
Q1
$265K Hold
321
0.26% 42
2024
Q4
$248K Buy
+321
New +$266K 0.24% 41

Other funds holding LLY

Capstone Wealth Management (Alabama)'s LLY Position: Q2 2026 in Review

Capstone Wealth Management (Alabama) increased its Eli Lilly (LLY) stake by 118% in Q2 2026, buying an estimated $606K and bringing the position to 1,096 shares worth $1.31M. The position accounts for 0.61% of the portfolio, ranked #23.

Capstone Wealth Management (Alabama) first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Capstone Wealth Management (Alabama) held 1,096 shares of Eli Lilly worth $1.31M as of Q2 2026.
  • Capstone Wealth Management (Alabama) bought 593 Eli Lilly shares in Q2 2026, an estimated $606K.
  • Eli Lilly made up 0.61% of Capstone Wealth Management (Alabama)'s portfolio in Q2 2026, its #23 holding.
  • Capstone Wealth Management (Alabama) first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Capstone Wealth Management (Alabama)'s 13F filing for Q2 2026, filed 23 Jul 2026.